Ondansetron ODT 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FBE48
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,156
Award facts
- Contract value 100% obligated
- $13,156.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order on September 4, 2025, by the Defense Logistics Agency (DLA) to supply Ondansetron ODT 4 mg tablets in quantities of 30 for a ceiling value of $13,156.25. This is a firm fixed-price, non-set-aside contract with a completion date of September 5, 2025, and performance to be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to prevent nausea and vomiting. This delivery order represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract (IDC) with DLA Troop Support Medical, designated as SPE2DX.
AmerisourceBergen's SPE2DX prime contract, valued at approximately $1 billion through December 2026, serves as the primary vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen is a critical vendor for the Defense Health Agency and other federal healthcare systems. The company's contract portfolio with DLA demonstrates its capability to fulfill competitive procurement requirements for a diverse range of medications and medical supplies across multiple therapeutic domains, establishing AmerisourceBergen as a key supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FBE48?
SPE2DB25FBE48 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FBE48 worth?
The government has obligated $13,156 on SPE2DB25FBE48.
Is contract SPE2DB25FBE48 an order under another contract?
Yes. SPE2DB25FBE48 is a delivery order under SPE2DB22D3009, an indefinite delivery contract.
Was contract SPE2DB25FBE48 competed?
The extent of competition for SPE2DB25FBE48 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award